Duration of Immunogenicity of the Recombinant Rift Valley Fever Vaccine MP-12 del-NSm21/384 in Sheep
RIFT VALLEY FEVER
31May
31May
In‑vitro and in‑vivo study of the interference between Rift Valley fever virus (clone 13) and Sheeppox/Limpy Skin disease viruses
RIFT VALLEY FEVER
31May
Safety and immunogenicity of the Rift Valley fever arMP-12 DNSm21/ 384 candidate vaccine in pregnant ewes
RIFT VALLEY FEVER
31May
Comparative thermo-stability of two Rift Valley fever virus vaccine candidate CL13T with a recombinant arMP-12ΔNSm21/384
RIFT VALLEY FEVER
31May
Safety and immunogenicity of a live attenuated Rift Valley Fever recombinant arMP-12DNSm21/384 vaccine candidate for sheep, goats and calves
RIFT VALLEY FEVER
31May
Safety and immunogenecity of a live attenuated Rift Valley fever vaccine (CL13T) in camels
RIFT VALLEY FEVER
31May
Evaluation of the Safety and Efficacy of a Live Attenuated Thermostable Rift Valley Fever Vaccine in Sheep, Goats and Cattle
RIFT VALLEY FEVER
31May
Heat stability of the Rift Valley Fever Virus Clone 13 live vaccines
RIFT VALLEY FEVER